Medibank Private Ltd.

As of June 30, 2026, MEDIBANK PRIVATE LTD carries a market capitalization of 9.02B, placing it among publicly traded companies globally. Its enterprise value stands at 8.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MEDIBANK PRIVATE LTD's next confirmed earnings release is scheduled for February 24, 2027.

As of June 30, 2026, MEDIBANK PRIVATE LTD has 275.36M shares outstanding.

As of June 30, 2026, MEDIBANK PRIVATE LTD trades at a trailing price-to-earnings ratio of 20.40. The price-to-sales ratio is 1.39, and the price-to-book ratio stands at 5.36.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.33 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 8.59B versus a market cap of 9.02B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, MEDIBANK PRIVATE LTD posted a return on equity (ROE) of 26.80, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 13.51, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 24.23, useful for judging operating efficiency across full business cycles. The company generates approximately 1.29M in revenue per employee across its workforce of 5,001.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, MEDIBANK PRIVATE LTD recorded 194.88M in income tax expense. That works out to an effective tax rate of 30.35, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 642.15M, leaving 442.01M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 16, 2026, MEDIBANK PRIVATE LTD's stock has gained approximately 52.14% over the past 52 weeks.

Over the twelve months ended June 30, 2026, MEDIBANK PRIVATE LTD generated 6.47B in revenue and converted that into 442.01M in net income, yielding earnings per share of 1.62.

As of June 30, 2026, MEDIBANK PRIVATE LTD holds 606.51M in cash and equivalents against 189.55M in total debt, resulting in a net debt position of -369.90M.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, MEDIBANK PRIVATE LTD paid dividends of 1.30 per share. The dividend payout ratio of 79.00 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 4.64, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to MEDIBANK PRIVATE LTD shareholders.